Press Releases

Mar 19, 2026 6:00am EDT

Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01

Mar 18, 2026 6:00am EDT

Greenwich LifeSciences Provides Update on Upcoming AACR Meeting

Mar 17, 2026 6:00am EDT

Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01

Mar 16, 2026 6:00am EDT

Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01

Mar 03, 2026 6:00am EST

Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01

Feb 24, 2026 6:00am EST

Greenwich LifeSciences Announces Acceptance of Two Abstracts at AACR Annual Meeting 2026

Jan 27, 2026 6:00am EST

Greenwich LifeSciences Provides Update on FLAMINGO-01 Cash Burn Rate and Financing Strategy

Jan 22, 2026 6:00am EST

Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01

Dec 29, 2025 6:00am EST

Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026

Dec 22, 2025 6:00am EST

Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy